These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease. Pramoolsinsap C, Poovorawan Y, Sura T, Theamboonlers A, Busagorn N, Kurathong S. Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):480-90. PubMed ID: 10437943 [Abstract] [Full Text] [Related]
3. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Leone N, Rizzetto M. Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144 [Abstract] [Full Text] [Related]
4. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Shindo M, Ken A, Okuno T. Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234 [Abstract] [Full Text] [Related]
5. How to use virological tools for the optimal management of chronic hepatitis C. de Leuw P, Sarrazin C, Zeuzem S. Liver Int; 2011 Jan 01; 31 Suppl 1():3-12. PubMed ID: 21205131 [Abstract] [Full Text] [Related]
6. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C. De Mitri MS, Morsica G, Chen CH, Mele L, Baccarini P, Chianese R, Piccinini A, Lazzarin A, Pisi E. Ital J Gastroenterol Hepatol; 1997 Jun 01; 29(3):255-61. PubMed ID: 9646218 [Abstract] [Full Text] [Related]
7. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC. Arthritis Rheum; 2002 Dec 01; 46(12):3317-26. PubMed ID: 12483738 [Abstract] [Full Text] [Related]
8. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy. Kessler HH, Pierer K, Santner BI, Vellimedu SK, Stelzl E, Marth E, Fickert P, Stauber RE. J Hum Virol; 1998 Dec 01; 1(5):314-9. PubMed ID: 10195258 [Abstract] [Full Text] [Related]
9. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis. Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P. Am J Gastroenterol; 2003 May 01; 98(5):1150-4. PubMed ID: 12809841 [Abstract] [Full Text] [Related]
10. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. Lee MH, Yang HI, Lu SN, Jen CL, Yeh SH, Liu CJ, Chen PJ, You SL, Wang LY, Chen WJ, Chen CJ. J Clin Oncol; 2010 Oct 20; 28(30):4587-93. PubMed ID: 20855826 [Abstract] [Full Text] [Related]
11. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response. Chu CM, Sheen IS, Liaw YF. Infection; 2004 Jun 20; 32(3):153-6. PubMed ID: 15188075 [Abstract] [Full Text] [Related]
12. Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus. Nakamura H, Ogawa H, Kuroda T, Yamamoto M, Enomoto H, Kishima Y, Yoshida K, Ito H, Matsuda M, Noguchi S. Hepatogastroenterology; 2002 Jun 20; 49(47):1373-6. PubMed ID: 12239945 [Abstract] [Full Text] [Related]
13. Prevention of hepatocellular carcinoma complicating chronic hepatitis C. Ueno Y, Sollano JD, Farrell GC. J Gastroenterol Hepatol; 2009 Apr 20; 24(4):531-6. PubMed ID: 19368633 [Abstract] [Full Text] [Related]
14. Treatment predictors of a sustained virologic response in hepatitis B and C. Kau A, Vermehren J, Sarrazin C. J Hepatol; 2008 Oct 20; 49(4):634-51. PubMed ID: 18715665 [Abstract] [Full Text] [Related]
15. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model. Saab S, Hunt DR, Stone MA, McClune A, Tong MJ. Liver Transpl; 2010 Jun 20; 16(6):748-59. PubMed ID: 20517909 [Abstract] [Full Text] [Related]
16. Clinical significance of TT virus infection in patients with chronic hepatitis C. Zein NN, Arslan M, Li H, Charlton MR, Gross JB, Poterucha JJ, Therneau TM, Kolbert CP, Persing DH. Am J Gastroenterol; 1999 Oct 20; 94(10):3020-7. PubMed ID: 10520863 [Abstract] [Full Text] [Related]
17. Advances in the treatment of hepatitis C. Lawrence SP. Adv Intern Med; 2000 Oct 20; 45():65-105. PubMed ID: 10635046 [Abstract] [Full Text] [Related]
18. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon. Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR. Hepatology; 2001 Mar 20; 33(3):704-7. PubMed ID: 11230751 [Abstract] [Full Text] [Related]
19. Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C. Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H. J Gastroenterol Hepatol; 2006 Jan 20; 21(1 Pt 1):122-8. PubMed ID: 16706823 [Abstract] [Full Text] [Related]
20. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P. Gastroenterology; 2008 Sep 20; 135(3):821-9. PubMed ID: 18593587 [Abstract] [Full Text] [Related] Page: [Next] [New Search]